top
Please input keywords
Order
*Country
日本
アメリカ
中国
オーストラリア
シンガポール
イギリス
フランス
ドイツ
スイス
イタリア
カナダ
韓国
オランダ
ベルギー
スウェーデン
その他
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hTFR1 mice
Strain Name
C57BL/6-Tfrctm1(TFRC)Bcgen/Bcgen
Common Name  B-hTFR1 mice
Background C57BL/6 Catalog number  110861
Related Genes 
T9; TR; TFR; p90; CD71; TFR1; TRFR; IMD46
NCBI Gene ID
22042

mRNA expression analysis



Strain specific analysis of TFR1 gene expression in wild type (WT) mice and B-hTFR1 mice by RT-PCR. 
Mouse Tfrc mRNA was detectable only in splenocytes of WT mice (+/+). Human TFRC mRNA was detectable only in homozygous B-hTFR1 mice (H/H) but not in WT mice (+/+). 


Protein expression analysis in erythroid cells



Strain specific TFR1 expression analysis in homozygous B-hTFR1 mice by flow cytometry. 

Bone marrow was collected from wild type (WT) mice (+/+) and homozygous B-hTFR1 mice (H/H), and analyzed by flow cytometry with species-specific anti-TFR1 antibody. Mouse TFR1 was detectable in WT mice (+/+). Human TFR1 was exclusively detectable in homozygous B-hTFR1 mice (H/H) but not in WT mice (+/+).


Protein expression analysis in brain


from clipboard



Strain specific TFR1 expression analysis in homozygous B-hTFR1 mice by Immunofluorescence staining. Brain was collected from wild type (WT) mice and homozygous B-hTFR1 mice (female,8 week old) and processed into paraffin sections. The paraffin sections were stained using an species-specific anti-human TFR1 antibody (green). Brain tissues were co-stained with an anti-mouse CD31 antibody to visualize microvascular endothelial cells (red). Representative results of WT mice (A) and homozygous B-hTFR1 mice (B) are shown. The results indicated that human TFR1 was exclusively detectable on brain microvascular endothelium of homozygous B-hTFR1 mice, but not in WT mice.



In vivo PK evaluation of anti-human TFR1 BsAbs



In vivo pharmacokinetic (PK)  evaluation of anti-human TFR1 bispecific antibodies (BsAbs).

B-hTFR1 mice were injected with control IgG (10 mpk) and anti-human TFR1 BsAbs (10.9 mpk) provided by a client via tail vein. Brain and serum were taken for in vivo PK evaluation. Brain concentrations(A), serum concentrations (B), and brain-to-serum ratio (C) of anti-human TFR1 BsAbs were quantified. As shown in panel, both BsAbs exhibited higher serum clearance and enhanced brain exposure after dose. The results confirmed that brain of B-hTFR1 mice enables uptake of an intravenously administered anti-human TFR1 BsAbs and B-hTFR1 mice provide a powerful preclinical model for in vivo evaluation of effective delivery of protein therapeutics to the central nervous system (CNS).Graphs represent mean ± SEM.


Analysis of spleen leukocytes cell subpopulations in B-hTFR1 mice



Analysis of spleen leukocyte subpopulations by FACS.
Splenocytes were isolated from female C57BL/6 and B-hTFR1 mice (n=3, 6 week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for CD45 population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cells, B cells, NK cells, dendritic cells, granulocytes, monocytes and macrophages in homozygous B-hTFR1 mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hTFR1 in place of its mouse counterpart does not change the overall development, differentiation or distribution of these cell types in spleen. Values are expressed as mean ± SEM.


Analysis of spleen T cell subpopulations in B-hTFR1 mice


Analysis of spleen T cell subpopulations by FACS.
Splenocytes were isolated from female C57BL/6 and B-hTFR1 mice (n=3, 6 week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for CD3 T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of CD8+ T cells, CD4+ T cells and Treg cells in homozygous B-hTFR1 mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hTFR1 in place of its mouse counterpart does not change the overall development, differentiation or distribution of these T cell sub types in spleen. Values are expressed as mean ± SEM.


Analysis of lymph node leukocytes cell subpopulations in B-hTFR1 mice



Analysis of lymph node leukocyte subpopulations by FACS.
Leukocytes were isolated from female C57BL/6 and B-hTFR1 mice (n=3, 6 week-old). Flow cytometry analysis of the leukocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for CD45 population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cells, B cells and NK cells in homozygous B-hTFR1 mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hTFR1 in place of its mouse counterpart does not change the overall development, differentiation or distribution of these cell types in lymph node. Values are expressed as mean ± SEM.


Analysis of lymph node T cell subpopulations in B-hTFR1 mice


Analysis of lymph node T cell subpopulations by FACS.
Leukocytes were isolated from female C57BL/6 and B-hTFR1 mice (n=3, 6 week-old). Flow cytometry analysis of the leukocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for CD3 T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of CD8+ T cells, CD4+ T cells and Treg cells in homozygous B-hTFR1 mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hTFR1 in place of its mouse counterpart does not change the overall development, differentiation or distribution of these T cell sub types in lymph node. Values are expressed as mean ± SEM.


Analysis of blood leukocytes cell subpopulations in B-hTFR1 mice



Analysis of blood leukocyte subpopulations by FACS.
Blood cells were isolated from female C57BL/6 and B-hTFR1 mice (n=3, 6 week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for CD45 population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cells, B cells, NK cells, dendritic cells, granulocytes, monocytes and macrophages in homozygous B-hTFR1 mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hTFR1 in place of its mouse counterpart does not change the overall development, differentiation or distribution of these cell types in blood. Values are expressed as mean ± SEM.


Analysis of blood T cell subpopulations in B-hTFR1 mice


Analysis of blood T cell subpopulations by FACS.
Blood cells were isolated from female C57BL/6 and B-hTFR1 mice (n=3, 6 week-old). Flow cytometry analysis of the leukocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for CD3 T cell population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of CD8+ T cells, CD4+ T cells and Treg cells in homozygous B-hTFR1 mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hTFR1 in place of its mouse counterpart does not change the overall development, differentiation or distribution of these T cell sub types in blood. Values are expressed as mean ± SEM.


Blood routine test in B-hTFR1 mice

from clipboard


Complete blood count (CBC). 
Blood from female C57BL/6 and B-hTFR1 mice (n=5, 6 week-old) were collected and analyzed for CBC. There was no differences among any measurement between C57BL/6 and B-hTFR1 mice, indicating that introduction of hTFR1 in place of its mouse counterpart does not change blood cell composition and morphology. Values are expressed as mean ± SEM.


Blood chemistry of B-hTFR1 mice

from clipboard


Blood chemistry tests of B-hTFR1 mice. 
Serum from the C57BL/6 and B-hTFR1 mice (n=5, 6 week-old) were collected and analyzed for levels of ALT and AST. There was no differences on either measurement between C57BL/6 and B-hTFR1 mice, indicating that introduction of hTFR1 in place of its mouse counterpart does not change ALT and AST levels or health of liver. Values are expressed as mean ± SEM.